Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2010

Open Access 01-12-2010 | Letter to the Editor

Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response

Authors: Rajiv Raman, Aditi Gupta

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Login to get access

Abstract

A response to Jorge Esteves, Carolina Maurente da Rosa, Caroline Kaercher Kramer, Luiz Eduardo Osowski, Stéfano Milano and Luís Henrique Canani: Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation. Diabetology & Metabolic syndrome 2009, 1:13.
Literature
1.
go back to reference Fischer F: Spontaneous regression of diabetic retinopathy (author's transl). Klin Monbl Augenheilkd. 1976, 169: 602-605.PubMed Fischer F: Spontaneous regression of diabetic retinopathy (author's transl). Klin Monbl Augenheilkd. 1976, 169: 602-605.PubMed
2.
go back to reference Han JR, Ju WK, Park IW: Spontaneous regression of neovascularization at the disc in diabetic retinopathy. Korean J Ophthalmol. 2004, 18: 41-46.CrossRefPubMed Han JR, Ju WK, Park IW: Spontaneous regression of neovascularization at the disc in diabetic retinopathy. Korean J Ophthalmol. 2004, 18: 41-46.CrossRefPubMed
3.
go back to reference Murdoch JR, Bibby K, Barrie T, Hammer HM, Maccuish A: Spontaneous regression of pre-proliferative diabetic retinopathy. Practical Diabetes International. 2005, 10: 110-113. 10.1002/pdi.1960100312.CrossRef Murdoch JR, Bibby K, Barrie T, Hammer HM, Maccuish A: Spontaneous regression of pre-proliferative diabetic retinopathy. Practical Diabetes International. 2005, 10: 110-113. 10.1002/pdi.1960100312.CrossRef
4.
go back to reference Uthra S, Raman R, Mukesh BN, Padmaja KR, Sharma T, McCarty CA, Kumaramanickavel G: Genetics of Diabetic Retinopathy. Int J Hum Genet. 2008, 8: 155-159. Uthra S, Raman R, Mukesh BN, Padmaja KR, Sharma T, McCarty CA, Kumaramanickavel G: Genetics of Diabetic Retinopathy. Int J Hum Genet. 2008, 8: 155-159.
5.
go back to reference Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T: Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications. 2002, 16: 391-394. 10.1016/S1056-8727(02)00187-3.CrossRefPubMed Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T: Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications. 2002, 16: 391-394. 10.1016/S1056-8727(02)00187-3.CrossRefPubMed
6.
go back to reference Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T: Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet. 2003, 24: 41-48. 10.1076/opge.24.1.41.13889.CrossRefPubMed Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T: Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet. 2003, 24: 41-48. 10.1076/opge.24.1.41.13889.CrossRefPubMed
7.
go back to reference Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Arokiasamy T, Sukumar B, Vidhya A, Joseph B, Sharma T, Gopal L: Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Res Clin Pract. 2001, 54: 89-94. 10.1016/S0168-8227(01)00269-8.CrossRefPubMed Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Arokiasamy T, Sukumar B, Vidhya A, Joseph B, Sharma T, Gopal L: Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Res Clin Pract. 2001, 54: 89-94. 10.1016/S0168-8227(01)00269-8.CrossRefPubMed
8.
go back to reference Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Rajendran V, Sukumar B, Ramprasad VL, Sharma T: Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clin Genet. 2002, 61: 344-348. 10.1046/j.0009-9163.2002.00251.x.CrossRefPubMed Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Rajendran V, Sukumar B, Ramprasad VL, Sharma T: Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clin Genet. 2002, 61: 344-348. 10.1046/j.0009-9163.2002.00251.x.CrossRefPubMed
9.
go back to reference Uthra S, Raman R, Mukesh BN, Padmaja KR, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G: Intron 4 VNTR of Endothelial Nitric Oxide Synthase (eNOS) Gene and Diabetic Retinopathy in Type 2 Patients in Southern India. Ophthalmic Genet. 2007, 28: 77-81. 10.1080/13816810701209669.CrossRefPubMed Uthra S, Raman R, Mukesh BN, Padmaja KR, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G: Intron 4 VNTR of Endothelial Nitric Oxide Synthase (eNOS) Gene and Diabetic Retinopathy in Type 2 Patients in Southern India. Ophthalmic Genet. 2007, 28: 77-81. 10.1080/13816810701209669.CrossRefPubMed
Metadata
Title
Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response
Authors
Rajiv Raman
Aditi Gupta
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-2-20

Other articles of this Issue 1/2010

Diabetology & Metabolic Syndrome 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine